Clifford Boese, MD
Orthopaedic Surgery · Council Bluffs, IANPI 1225036916
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,035 of the $18,293 with a category attached, or 71.3%. Medical Device Business Services, Inc. accounts for 72.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $8,664 and has fallen 99.6% since, to $37 in 2025.
Across 60 payments — averaging $304.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$13K
- Johnson & Johnson$3K
- Stryker$991
- Medtronic$722
- Zimmer Biomet$240
- Medacta USA, Inc.$120
- plus $187 from 8 others
Across 18 payments — averaging $2488.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$45K
What the payments were for
- Consulting fees$13,03571%
- Travel & lodging$3,05317%
- Food & beverage$2,20512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 10 | $13,229 |
| Johnson & Johnson | 15 | $2,804 |
| Stryker | 17 | $991 |
| Medtronic | 7 | $722 |
| Zimmer Biomet | 2 | $240 |
| Medacta USA, Inc. | 1 | $120 |
| Davol Inc. | 1 | $60 |
| Innovation Technologies Inc | 1 | $27 |
| Linvatec Corporation | 1 | $24 |
| AbbVie | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| Teleflex LLC | 1 | $15 |
| Averitas Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATTUNE$13,151
- Velys$2,109
- MAKO$681
- AQUAMANTYS$582
- G7$120
- Arcos$120
- GMK SPHERE$120
- TRUMATCH$116
How this compares
$18,293 in reported general payments places this provider in the 85th percentile of 219 orthopaedic surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 61 | $1,490 |
| Gabapentin | 17 | $211 |
| Meloxicam | 49 | $80 |
| Tramadol Hcl | 14 | $37 |
| Cephalexin | 13 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Council Bluffs
- Thomas AtteberryCouncil Bluffs$8K
- John CallaghanIowa City$23.3M
- Brian AdamsIowa City$865K
- Cesar de Cesar NettoIowa City$693K
- Lynn NelsonBelmond$285K
- Robert WestermannIowa City$182K
- Joseph BuckwalterIowa City$132K
- Brendan PattersonIowa City$122K
- Nicholas BedardIowa City$59K
- Charles ClarkIowa City$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.